Tech Company Financing Transactions
Tamir Biotechnology Funding Round
Tamir Biotechnology closed a $1.5 million funding round on 5/20/2016. Backers included private investors.
Transaction Overview
Company Name
Announced On
5/20/2016
Transaction Type
Venture Equity
Amount
$1,524,978
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
51 JFK Pkwy. 1st Floor West 108
Short Hills, NJ 07078
USA
Short Hills, NJ 07078
USA
Phone
Website
Email Address
Overview
TamirBio is a clinical stage antiviral therapeutics company engaged in the discovery and development of a new class of prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jamie Sulley
Chief Financial Officer
Joanne Barsa
Browse more venture capital transactions:
Prev: 5/20/2016: Springbuk venture capital transaction
Next: 5/20/2016: TAXA venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs